| | Press and Media

Press Releases

view by year
PRESS RELEASEApril 07, 2014
NanoString Technologies Introduces Novel PanCancer Gene Expression Panel for Multiplexed Pathway Analysis
read more
PRESS RELEASEApril 03, 2014
NanoString Technologies Announces $45 Million Term Loan Agreement with Capital Royalty
read more
PRESS RELEASEMarch 13, 2014
Newly Published Analytical Validation Study Shows Precision and Reproducibility of PAM50-Based Prosigna Breast Cancer Assay in Multiple Clinical Testing Laboratories
read more
PRESS RELEASEFebruary 26, 2014
NanoString Technologies Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook
read more
PRESS RELEASEFebruary 12, 2014
Study Confirms Ability of the Prosigna Assay to Assess Risk of Late Distant Recurrence in Postmenopausal Women with Estrogen Receptor-Positive Breast Cancer
read more
PRESS RELEASEFebruary 11, 2014
NanoString Technologies Launches Commercial Reagents to Enable Laboratories to Rapidly Develop Tests from Translational Research Discoveries
read more
PRESS RELEASEJanuary 23, 2014
NANOSTRING TECHNOLOGIES PRICES FOLLOW-ON OFFERING
read more

Media Coverage

view by year
September 10, 2013
NCI Scientists Identify Targets for Melanoma Immunotherapy
read more
September 10, 2013
In BD Deal, NanoString Looks to Broaden Appeal to Single-Cell Genomics Researchers
read more
April 17, 2013
NanoString Nabs License to Liver Cancer Gene Signature
read more
February 19, 2013
NanoString Starts Selling First Breast Cancer Test in EU - (on Xconomy)
read more